English

This webinar includes a panel of experts discussing the questions healthcare providers have about using 3 months of isoniazid and rifapentine once weekly (3HP) to treat latent TB infection (LTBI).

This report details the activities of the International Union Against Tuberculosis and Lung Disease (The Union) for the year 2008.

Luís Figo’s "I Am Stopping Tuberculosis" campaign consists of materials including posters, computer wallpaper, and postcards delivering key messages on tuberculosis.

This report summarizes a study of 101 women who were newly diagnosed as HIV positive and controls to determine reasons for the behaviors that put them at risk for HIV infection. Poverty, partner risk behavior, and alcohol and drug use were among reasons for their behavior. Findings demonstrate the need for multiple approaches to reducing HIV infection among black women.

This handbook is a reference tool for use by national tuberculosis (TB) program managers, clinicians and nurses, public health decision-makers and technical and implementing partners committed to the prevention, care, diagnosis and treatment of drug-resistant TB.

This webinar was created for physicians and other licensed medical professionals who diagnose and treat latent tuberculosis infection (LTBI). The webinar focuses on risk assessment, diagnosis, and treatment options for LTBI.

This online course covers how to diagnose, treat, and prevent childhood TB. The course consists of six modules: epidemiology, diagnosis, treatment, TB/HIV, prevention, and practice. The content is based on the World Health Organization's "Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children" and the Union's "Desk Guide for Diagnosis and Management of TB in Children."

This video provides information regarding pediatric TB.

This website provides access to information regarding childhood TB, including online courses, educational resources, and an online community.

This fact sheet provides a summary of WHO recommendations on using the Xpert MTB/RIF assay for people living with HIV.